Literature DB >> 19929903

What are 'true normal' liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea.

Seung Up Kim1, Gi Hong Choi, Woong Kyu Han, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Jin Sub Choi, Seung Choul Yang, Eun Hee Choi, Sang Hoon Ahn, Kwang-Hyub Han, Chae Yoon Chon.   

Abstract

AIMS: To identify the normal range of liver stiffness (LS) values by recruiting healthy living liver and kidney donors in South Korea.
METHODS: Liver stiffness measurement (LSM) was performed in 69 healthy living liver and kidney donors who were admitted for transplantation. None of the subjects suffered from diabetes mellitus, hypertension, hepatitis B virus infection, hepatitis C virus infection, heart dysfunction, liver dysfunction or metabolic syndrome.
RESULTS: LSM failure rate was 2.7%. Among 12 liver donors (17.4%) with available liver histology, eight showed normal liver histology and four showed liver steatosis of <5% of the hepatocytes. The mean age of our study population was 38.9+/-11.9 years (35 men and 34 women), with a mean LS value of 4.6+/-0.5 kPa (range 3.3-5.6 kPa). LS values were not significantly different between men (4.6+/-0.6 kPa) and women (4.5+/-0.5 kPa, P=0.636), nor were they significantly different according to age (P=0.851). Using the fifth and 95th percentiles, we determined the normal range of LS values to be 3.9-5.3 kPa.
CONCLUSIONS: We identified the normal range of LS values and found that LS values were not significantly influenced by age and gender.

Entities:  

Mesh:

Year:  2009        PMID: 19929903     DOI: 10.1111/j.1478-3231.2009.02172.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  23 in total

1.  Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation.

Authors:  Ki Tae Yoon; Sun Min Lim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Mong Cho; Jun Woo Lee; Seung Up Kim
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

2.  Transient elastography in chronic hepatitis B: an Asian perspective.

Authors:  Seung Up Kim; Kwang-Hyub Han; Sang Hoon Ahn
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

3.  Point quantification elastography in the evaluation of liver elasticity in healthy volunteers: a reliability study based on operator expertise.

Authors:  Cristina Felicani; Chiara De Molo; Horia Stefanescu; Fabio Conti; Elena Mazzotta; Veronica Gabusi; Elena Nardi; Antonio Maria Morselli-Labate; Pietro Andreone; Carla Serra
Journal:  J Ultrasound       Date:  2018-05-22

4.  Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea.

Authors:  Young Eun Chon; Kyu Sik Jung; Kwang Joon Kim; Dong Jin Joo; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Seung Up Kim
Journal:  Dig Dis Sci       Date:  2014-08-14       Impact factor: 3.199

5.  Measurement of real-time tissue elastography in a phantom model and comparison with transient elastography in pediatric patients with liver diseases.

Authors:  Jens-Peter Schenk; Gerhard Alzen; Volker Klingmüller; Ulrike Teufel; Saroa El Sakka; Guido Engelmann; Buket Selmi
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

6.  Normal liver stiffness: A study in living donors with normal liver histology.

Authors:  Ayman Alsebaey; Naglaa Allam; Khalid Alswat; Imam Waked
Journal:  World J Hepatol       Date:  2015-05-18

7.  Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders.

Authors:  Hirsh D Trivedi; Steven C Lin; Daryl T Y Lau
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-10

Review 8.  Non-invasive diagnosis of hepatitis B virus-related cirrhosis.

Authors:  Sangheun Lee; Do Young Kim
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

9.  The concomitant use of meloxicam and methotrexate does not clearly increase the risk of silent kidney and liver damages in patients with rheumatoid arthritis.

Authors:  Hee-Jin Park; Min-Chan Park; Yong-Beom Park; Soo-Kon Lee; Sang-Won Lee
Journal:  Rheumatol Int       Date:  2013-12-22       Impact factor: 2.631

10.  Concurrent use of methotrexate and celecoxib increases risk of silent liver fibrosis in rheumatoid arthritis patients with subclinical reduced kidney function.

Authors:  Jin Su Park; Min-Chan Park; Yong-Beom Park; Soo-Kon Lee; Sang-Won Lee
Journal:  Clin Rheumatol       Date:  2014-06-20       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.